Superworth

IDEXX Laboratories PE ratio IDXX

Share price divided by earnings per share over the last twelve months, since 2011.

Today, Nov 3, 2026
46.5×
10-year median
54.9×
Against its 10-year history
20th
percentile: 0 is its lowest day, 100 its highest
10-year range
35.5× to 89.4×
Peer median
37.9×

IDEXX Laboratories' PE ratio is 46.5× as of Nov 3, 2026: a share price of $661.03 against $14.22 of earnings per share over the last twelve months.

That is below its ten-year median of 54.9×, lower than on 80% of days in the last ten years.

Over that time it ranged from 35.5× in Sep 2026 to 89.4× in Jan 2021.

The median for 10 diagnostics and research stocks of a similar size is 37.9×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far47.2×35.5×56.7×
202554.6×36.6×59.7×
202440.0×39.8×58.4×
202356.6×41.5×66.7×
202251.8×38.5×64.3×
202175.4×67.2×89.4×
202087.1×37.6×87.1×
201954.8×47.2×64.3×
201850.0×49.7×78.0×
201750.6×47.8×64.9×
201649.9×34.8×52.2×
201539.6×34.2×46.1×
201438.7×30.9×39.1×
201331.0×25.3×32.5×
201230.0×28.4×33.8×
201128.3×25.5×33.4×

Against its peers

Companies in Medical - Diagnostics & Research nearest IDEXX Laboratories' size, closest first, today.

CompanyPE ratio
IDXXIDEXX Laboratories46.5×
AAgilent Technologies34.5×
WATWaters118×
IQVIQVIA32.0×
ILMNIllumina44.0×
MTDMettler-Toledo International38.4×
LHLabcorp29.4×
DGXQuest Diagnostics24.9×
MEDPMedpace38.0×
DHRDanaher37.9×
RVTYRevvity72.2×
Peer median37.9×

Where IDEXX Laboratories ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on IDEXX Laboratories

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.